Activity and Health in Nursing Homes

March 29, 2022 updated by: Norwegian University of Science and Technology

The Association Between Physical Behavior, Sleep and Neuropsychiatric Symptoms in Nursing Homes

There is expected to be an increased need for full time nursing homes as the increase in number of older adults increases and the rate of dementia diagnosis happens simultaneous with the decrees of healthcare personnel the years to come. A lift in knowledge is needed to provide a better and more efficient healthcare to be better equipped to meet this societal challenge. Physical activity and sleep are important indicators of health, but also on effect of treatment and care for this frail population. Comprehensive mapping of personnel time spent on different tasks and older adults' physical function throughout a week gives a unique opportunity to gain new knowledge about everyday life in nursing homes. The main aim of this project is to describe associations between physical behavior, sleep and symptoms in residents in nursing homes in Trondheim Municipality and combine these with personnel time spent on different working tasks.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Norway
      • Trondheim, Norway
        • Trondheim Kommune

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All residents living full time in nursing homes. These are often frail older adults with reduced physical function, high number of medications and comorbidities.

Description

Inclusion Criteria:

All residents in nursing homes in Trondheim Municipality.

Exclusion Criteria:

Terminal residents or residents that can not stand or walk a few steps independently.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Axivity accelerometer
Time Frame: 7 days
Activity monitoring
7 days
Somnofy sleepmonitor
Time Frame: 7 days
Sleep monitoring
7 days
Short Physical Performance Battery (SPPB)
Time Frame: Baseline
Measurement of physical function
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time register
Time Frame: 7 days
Time used on different tasks during the work day
7 days
Neuropsychiatric Inventory (NPI)
Time Frame: Baseline
provide a brief assessment of neuropsychiatric symptomatology in routine clinical practice settings
Baseline
Dementia Staging Instrument (CDR)
Time Frame: Baseline
characterize six domains of cognitive and functional performance applicable to Alzheimer disease and related dementias
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Norwegian University of Science and Technology

Collaborators

Trondheim Kommune

Investigators

  • Study Chair: Ingrid Olsen, Trondheim Kommune

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 30, 2021

Primary Completion (Anticipated)

May 31, 2022

Study Completion (Anticipated)

May 31, 2022

Study Registration Dates

First Submitted

August 31, 2021

First Submitted That Met QC Criteria

August 31, 2021

First Posted (Actual)

September 8, 2021

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 29, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 157470

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on no intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe